AstriVax Therapeutics Revenue

Biotechnology Research • Leuven, Flemish Region, Belgium • 21-50 Employees

AstriVax Therapeutics revenue & valuation

Annual revenue	$250,000
Revenue per employee	$8,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$800,000
Total funding	$3,200,000

Key Contact at AstriVax Therapeutics

Hanne Callewaert

Chief Executive Officer

Company overview

Headquarters	Ambachtenlaan 1, Heverlee, Flemish Region 3001, BE
Website	astrivax.com
NAICS	541714
Employees	21-50
Socials

AstriVax Therapeutics Email Formats

AstriVax Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@astrivax.com), used 61.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@astrivax.com	61.5%
{first name}.{last name}	john.doe@astrivax.com	30.8%
{first initial}.{second initial}{last name}	j.odoe@astrivax.com	7.7%

About AstriVax Therapeutics

AstriVax Therapeutics is a European based, clinical-stage biopharmaceutical company, founded in 2022, that is pioneering immune interventions to treat chronic disease. The company has two prototype prophylactic assets in clinical phase and is developing its therapeutic assets to treat chronic HBV and clear high-risk HPV. AstriVax has a novel DNA-launched viral vector immunotherapy platform, Launch-iT, that is designed to create an inherent adjuvant effect to the target antigens, eliciting durable polyfunctional CD8+ and CD4+ T cell responses and robust humoral immunity. Through Launch-iT, the company has the potential to develop best-in-class immunotherapy treatments.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Senior

Employees by Department

AstriVax Therapeutics has 14 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore AstriVax Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-12	9	$3,200,000

Funding Insights

$3,200,000

Total funding amount

$3,200,000

Most recent funding amount

Number of funding rounds

AstriVax Therapeutics Tech Stack

Discover the technologies and tools that power AstriVax Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

Amazon Web Services

PaaS

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Nginx

Reverse proxies

PHP

Programming languages

Open Graph

Miscellaneous

Vimeo

Video players

WordPress

Blogs

RankMath SEO

SEO

Bootstrap

UI frameworks

Google Analytics

Analytics

Frequently asked questions

AstriVax Therapeutics is located in Leuven, Flemish Region, BE.

AstriVax Therapeutics generates an estimated annual revenue of $250,000. This revenue figure reflects the company's market position and business performance in its industry.

AstriVax Therapeutics has an estimated valuation of $800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AstriVax Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

AstriVax Therapeutics has raised a total of $3,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at AstriVax Therapeutics

Hanne Callewaert

Chief Executive Officer

4.8

40,000 users